Why the Stock Market's 'Fear Index' Has Normalized Faster Than Ever Before
The Trump Administration's various tariff pauses have given investors confidence that tariffs will ultimately settle well below the rates proposed in early April.
Strong first-quarter earnings have also reassured investors concerned that tariffs will drag on growth.It's been a year of such extremes on Wall Street that even volatility measures have been historically volatile.
The Cboe Volatility Index (VIX), otherwise known as 'the fear index,' closed above 40 for the first time since 2020 in early April when President Trump sent the stock market into a tailspin with his 'Liberation Day' tariffs. Then, starting on April 9, when Trump paused most of those tariffs for 90 days, the VIX began a rapid descent.
From the close on April 10 to May 12, the VIX slid from 40.72 to less than 20, the level that many consider the delineator between normal and elevated volatility. The 21-day slide was the fastest the VIX has settled back into normal territory in its history going back to 1990, according to a recent analysis from Bespoke Investment Management.
Easing trade tensions has been the primary driver of the VIX's decline in recent weeks. U.S. and Chinese officials agreed last weekend to slash their respective tariff rates for 90 days while the two countries discuss a more lasting end to their tit-for-tat trade war. When officials announced the agreement on Monday, the VIX fell below 20 and the S&P 500 erased the last of its 'Liberation Day' losses.
The VIX closed Friday at 17.24, down more than 20% from a week earlier.
Trump's various tariff pauses 'gave a lot of portfolio managers the confidence that the off ramp was there,' said David Kostin, chief U.S. equities strategist at Goldman Sachs Research.
But the "off ramp" hasn't returned tariffs to their former levels; it's put them on a new path entirely. Commerce Secretary Howard Lutnick on Sunday wrote off the possibility of lowering tariffs below 10%. The effective U.S. tariff rate is currently 17.83%, up from 2.42% at the beginning of the year and only slightly below the 22.44% rate set on 'Liberation Day.'
A solid first-quarter earnings season has helped to smooth over some lingering concerns about the drag tariffs could have on economic growth. Heading into this week, the S&P 500 was on track to report earnings growth of more than 13%, well above the 7% expected at the end of March.
Plenty of uncertainty about the outlook remains. 'Liberation Day' tariffs are set to resume in early July, right around the time companies begin reporting earnings for the quarter in which the bulk of tariffs took effect. That period could see a return to April's volatility if the White House can't reach agreements with the dozens of countries it has threatened with tariffs.
Read the original article on Investopedia
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Otis Worldwide Earnings Preview: What to Expect
Valued at a market cap of $39.4 billion, Otis Worldwide Corporation (OTIS) is a global leader in the manufacturing, installation, and servicing of elevators and escalators, operating in over 1,400 locations worldwide. Headquartered in Farmington, Connecticut, Otis serves diverse sectors through its two main segments: New Equipment and Service. OTIS is expected to release its fiscal Q2 2025 earnings results on Wednesday, Jul. 23. Ahead of this event, analysts project Otis Worldwide to report an adjusted EPS of $1.01, a 4.7% decline from $1.06 in the year-ago quarter. The company has exceeded Wall Street's bottom-line estimates in two of the last four quarters while missing on two other occasions. In Q1 2025, OTIS surpassed the consensus adjusted EPS estimate by 1.1%. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Wolfspeed Is Surging After Filing for Bankruptcy. Is It Too Late to Touch WOLF Stock Here? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For fiscal 2025, analysts forecast the elevator maker to report adjusted EPS of $4.04, up 5.5% from $3.83 in fiscal 2024. Moreover, adjusted EPS is expected to grow 9.2% year-over-year to $4.41 in fiscal 2026. Otis Worldwide has risen over 4% over the past 52 weeks, underperforming the broader S&P 500 Index's ($SPX) over 13% return and the Industrial Select Sector SPDR Fund's (XLI) 22.2% gain over the same period. Despite beating expectations with Q1 2025 adjusted EPS of $0.92, Otis Worldwide saw its shares drop 6.7% on Apr. 23, as net sales fell 2.5% to $3.4 billion, missing consensus estimates. The decline was attributed to soft demand in the New Equipment segment, particularly in China's struggling property market, as well as concerns over a projected $45 million to $75 million hit to operating profit from U.S.-China tariffs. Still, the company raised its full-year revenue outlook to a range of $14.6 billion to $14.8 billion. Analysts' consensus view on Otis Worldwide stock is cautious, with an overall 'Hold' rating. Among 11 analysts covering the stock, two suggest a "Strong Buy," one "Moderate Buy," six give a "Hold," and two provide a "Strong Sell" rating. As of writing, OTIS is trading below the average analyst price target of $101.09. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
CNBC
33 minutes ago
- CNBC
These are JPMorgan's favorite stocks heading into July
JPMorgan added biotechnology firm Scholar Rock and construction supplies company Carlisle Companies to its list of top stock picks heading into July. The Wall Street investment bank updates its analyst focus list every month, encompassing JPMorgan's top stock ideas for growth, income, value and short investment strategies. JPMorgan also trimmed Vera Therapeutics and from the previous month's version of the list. JPMorgan's updated list comes as U.S. stocks finished the first half of 2025 at record highs. The S & P 500 advanced nearly 11% in the second-quarter, a turnaround from its April lows, which saw the broad market index flirt with a bear market. Here are some of the stocks on JPMorgan's focus list: Shares of Scholar Rock have pulled back by 18% in 2025, but are up 19% in the past month. Last month, the company reported favorable results from a its Phase 2 trial of weight loss drug apitegromab when used in combination with Eli Lilly's Mounjaro and Zepbound. JPMorgan's $46 per share price target implies about 29% upside from Tuesday's close of $35.55. SRRK YTD mountain Scholar Rock stock in 2025. Building materials maker Carlisle was also added to the JPMorgan monthly lost of recommendations. Shares have gained about 7% so far in 2025. Scottsdale, Arizona-based Carlisle recently completed the purchase of warehousing and packaging company Bonded Logistic. JPMorgan's $500 per share price target implies about 26% upside from Tuesday's close of $395.69. CSL YTD mountain Carlisle stock in 2025.
Bloomberg
35 minutes ago
- Bloomberg
Tensions Are Starting to Brew Over Waterways for US LNG Cargoes
One of the US largest exporters of liquefied natural gas, Venture Global Inc., is raising questions over how to share a common waterway with a planned neighbor — it's a move that underscores a coming bottleneck for shipping space in an energy sector that the Trump administration is supporting for increased exports. The US, already the biggest global exporter of the fuel, is on track to nearly double its current capacity with a massive buildout of six projects under construction in Texas and Louisiana. And even more are in advanced stages of development as President Donald Trump has made moves to increase the flow of cargoes from the US.
